FAF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FAF is a reasonable long-term buy for a beginner with $50,000-$100,000, but it is not a strong urgent buy at the current moment. My direct view is: buy a partial position now and add on weakness. The stock has supportive fundamentals, improving analyst sentiment, and favorable hedge fund activity, while the technical setup is neutral-to-soft in the very short term. For an impatient investor who does not want to wait for a perfect entry, this is still a constructive entry for a long-term portfolio.
Current price is 66.82, below the prior close of 67.84 and just under the pivot level of 68.431. The MACD histogram is negative at -0.346, showing short-term downside momentum, while RSI_6 at 47.661 is neutral and not oversold. Moving averages are converging, which suggests a consolidation phase rather than a strong trend. Support sits at 66.498 and 65.304, with resistance at 70.364 and 71.558. Overall, the chart is range-bound and slightly weak in the near term, but not technically broken.
["Analysts have recently raised price targets and kept bullish ratings after strong Q1 results.", "Stephens highlighted improving earnings power from commercial momentum, First American Trust, and AI/technology initiatives.", "Barclays cited positive commercial trends and a strong 2026 pipeline.", "Hedge funds are buying, with buying amount up 166.01% over the last quarter.", "The company is seen benefiting from improved profitability and better operating discipline."]
["No news in the last week, so there is no fresh near-term catalyst.", "Short-term technical momentum is weak, with a negative MACD histogram.", "The stock is trading slightly below key pivot resistance, showing lack of immediate breakout strength.", "Insider trading activity is neutral, so there is no insider confirmation.", "No recent congress trading data or influential figure trades are available."]
The latest quarter mentioned is Q1 2026. Financial commentary was strong: the company beat expectations, and analysts pointed to improving earnings power, strong commercial business performance, and upbeat management commentary around AI implementation. This suggests growth is being driven more by commercial momentum, better margins, and operational efficiency than by broad housing-market strength alone. The provided financial snapshot failed to supply full quarter line items, so the assessment is based on reported earnings and analyst commentary.
Analyst sentiment is clearly positive and improving. Over the past few weeks, Stephens, Keefe Bruyette, Truist, and Barclays all raised price targets, with targets ranging from $80 to $87 and multiple Buy/Overweight/Outperform ratings maintained. The recent trend is upward revisions after strong Q1 results. Wall Street pros see improving profitability, solid commercial execution, and AI-driven upside. The main con is that the stock is not showing strong technical momentum right now, so analysts are more bullish than the chart suggests.
